EDITORIAL Standard Nomenclature and Diagnostic Criteria in Toxicologic Pathology
Interest has been building for the last several years in the field of toxicologic pathology to have a Standardized System of Nomenclature and Diagnostic Criteria (SSNDC). The Society of Toxicologic Pathologists desires to institute procedures that will enable a standard system to be developed and utilized. The response at the afternoon session on the last day of the Gastrointestinal Toxicologic Pathology Symposium held in Philadelphia June 1-3,1987, confirmed that the Society should take the initiative and take action along these lines. In the experience of the Society over the last several years, as well as what can be learned from regulatory, governmental agencies and industrial institutions, the lack of such a system results in many problems including controversies and delays in approval processes.
The Society of Toxicologic Pathologists will attempt to take the lead role in establishing this standardized system. This will be accomplished by means of an extensive coordinated effort with input and support from representatives of the chemical and pharmaceutical industries, consultants, contract laboratories, and governmental agencies.
There will be a series of organ subcommittees set up and directed by a Coordinating Committee, comprised of Scott Eustis, Jerry Hardisty, Dick Garner, Spencer Streett, and Joe Burek. Efforts will be made by the Coordinating Committee and organ subcommittees to assure that all possible routes of input will be fulfilled and that there will be some consistency about the method of operation of the project. Input will be secured from many sources, including the general membership, regional discussion groups, other organizations such as American College of Veterinary Pathologists, Society of Toxicology, International Academy of Pathology, Armed Forces Institute of Pathology and International Life Sciences Institute, and International Federation of Toxicologic Pathology Societies, and regulatory agencies. Other classification systems currently used will be reviewed, including systems from industry, the National Toxicology 305
Program, the World Health Organization, SNOP, SNOMED, SNOVET, and others.
The Coordinating Committee has started by identifying key members to work on the different endocrine organs. These key members will be the initial organizers of the subcommittees. They will also serve as the contact persons desiring to work on specific organs. Once the subcommittees have an adequate number of members, a subcommittee chairman will be elected.
Contact persons and some members of the subcommittees identified to date for specific organs are as follows: These persons are proceeding to form the various organ committees and starting to develop their strategy to meet the overall goals of the Society. In the meantime, the Coordinating Committee has set up guidelines and is developing a consistent plan of action. The Coordinating Committee is also seeking input from the developing subcommittees.
A primary goal is for at least one endocrine organ subcommittee (preferably more if possible) to have a draft proposal of SSNDC for presentation to the general membership at the nomenclature session of the 1988 Symposium in Boston. Prior to that, it should have been reviewed and approved by the Coordinating Committee and the Executive Council. The other subcommittees will give status reports and secure additional input from the general membership at that time (see scheme below).
On an annual basis, the symposium will be the forum where all final proposals can be presented and discussed by the general membership. The proposals which are approved by the general membership will first be published in the STP Journal.
Final long-term goal will be the publication of Standard Nomenclature Diagnostic Criteria Guidelines Fascicle for each organ. It would not only contain the standard nomenclature and the diagnostic criteria, but also representative color illustrations, discussion, and bibliography. Where there had been some controversy or conflicts in the literature, they would be discussed and referenced. Initially, the concentration will be on rat and mouse lesions.
There are many advantages for all toxicologic pathologists to have standard nomenclature guidelines in our everyday work environment and with our regulatory interactions. We are looking forward to a project with extensive participation by the membership at large.
C. Spencer Streett, V.M.D.

